Tamoxifen may increase the risk of later tumours being more aggressiveBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7304.68/c (Published 14 July 2001) Cite this as: BMJ 2001;323:68
- Scott Gottlieb
- New York
If a woman who takes tamoxifen for breast cancer develops a cancer in her other previously healthy breast, the risk is higher that it will be of a more dangerous type than a contralateral cancer in a woman who has never taken the drug.
Researchers collected data on 8981 women with primary unilateral breast cancer aged at least 50 who had received adjunctive hormonal therapy but not chemotherapy (tamoxifen users) or had received neither hormonal therapy nor chemotherapy (tamoxifen non-users) (Journal of the National Cancer Institute 2001;93:1008-12).
The researchers identified contralateral breast cancers in 89 …
Log in using your username and password
Log in through your institution
Sign up for a free trial